Abbott’s Alinity S System Receives FDA’s Approval for Blood and Plasma Screening in the US

Abbott’s Alinity S System Receives FDA’s Approval for Blood and Plasma Screening in the US

Shots:

  • Alinity s System is designed to screen blood and plasma efficiently within a smaller space and helps improve the productivity of blood & plasma centers by maintaining its accuracy in the US
  • Alinity s consist of new features which include expanded capacity, speed and walk-away time with a facility of running more tests in less space, generating faster test results and minimizing human error
  • Abbott’s Alinity family is a harmonized solution for the screening of blood and plasma addressing the challenges of using multiple diagnostic platforms and simplifying diagnostic testing by providing quality results

Click here to read full press release/ article | Ref: Abbott | Image: Abbott